HMOX1 and acute myeloid leukemia: Research by Kannan et al. demonstrated that HO-1 expression is significantly higher in FLT3-ITD+ AML cells compared to FLT3-wild type cells, with patients exhibiting elevated HO-1 levels showing reduced survival rates.